Arkolith/Insider Trading/BTTX/Form 4

Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended

10% OwnerBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Apr 4, 2022
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Buy(P)3K$1.97$5K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2022Grant(A)235K—$0235K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-013342) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML